Workup for Hematuria in Male Patients
The appropriate workup for a male patient presenting with hematuria should include risk stratification, urinalysis, serum PSA testing, appropriate imaging, and cystoscopy based on risk factors. 1
Initial Risk Assessment
Risk stratification is essential to guide the extent of evaluation:
Risk Factors for Urologic Malignancy
- Age >60 years
- Smoking history
- Exposure to industrial chemicals
- Family history of renal cell carcinoma or genetic renal tumor syndrome
- Degree of hematuria (gross hematuria carries highest risk)
Diagnostic Evaluation Algorithm
Step 1: Confirm Hematuria
- Urinalysis to confirm presence of red blood cells
- Determine if microscopic (≥3-5 RBCs/HPF) or gross hematuria
- Assess for pyuria, bacteriuria, crystals, and casts
Step 2: Basic Laboratory Tests
- Complete metabolic panel (BUN, creatinine, electrolytes)
- Serum PSA measurement in men with at least a 10-year life expectancy 2
- Urine culture to rule out infection
Step 3: Imaging Based on Risk
Low-Risk Patients (age ≤40, <5 RBCs/HPF, no risk factors):
- Renal ultrasound
- Repeat urinalysis in 3 months
Intermediate/High-Risk Patients (age >40, ≥5 RBCs/HPF, or risk factors present):
- CT urography (92% sensitivity, 93% specificity) 1
- Alternative options if CT contraindicated:
- MR urography (renal insufficiency or contrast allergy)
- Renal ultrasound (younger patients)
Step 4: Cystoscopy
- Recommended for all patients with:
- Gross hematuria
- Age >40 with microscopic hematuria
- Risk factors for urologic malignancy
- Persistent unexplained hematuria
Step 5: Additional Testing Based on Clinical Suspicion
- Urine cytology for patients with:
- Irritative voiding symptoms
- Risk factors for carcinoma in situ 1
- Consider prostate biopsy if prostate cancer is suspected 2
Special Considerations
Benign Prostatic Hyperplasia (BPH)
- Common cause of hematuria in older men
- Digital rectal examination to assess prostate size
- Consider PSA testing as it may predict natural history of BPH 2
Acute Management
- For patients with gross hematuria and clots:
- Consider continuous bladder irrigation
- Monitor for urinary retention 3
Follow-up Recommendations
- Patients with negative initial evaluation should have repeat urinalysis within 12 months
- Persistent microscopic hematuria requires continued surveillance
- Consider nephrology referral if there is:
- Significant proteinuria
- Elevated creatinine
- eGFR <60 ml/min/1.73m² 1
Common Pitfalls to Avoid
Do not attribute hematuria to anticoagulant therapy without proper evaluation - these patients still require complete workup 1
Do not assume hematuria is due to UTI without supporting evidence of infection (pyuria, positive culture) 1
Do not ignore clinical changes such as new symptoms, gross hematuria, or increased degree of microscopic hematuria, as these should prompt immediate re-evaluation 1
Do not delay urologic referral for patients with gross hematuria, as the risk of malignancy exceeds 10% 4
Do not forget to consider non-urological causes of hematuria, including nephropathies, which may require nephrology consultation 5
By following this structured approach, clinicians can ensure appropriate evaluation of male patients presenting with hematuria, focusing on identifying potentially serious underlying conditions while avoiding unnecessary testing in low-risk individuals.